Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate against fractures in children with cerebral palsy
2014-002118-21Phase 2Completed
- Sponsor
- Randers Regional Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of zoledronic acid in cerebral palsy (CP), osteopenia and bone fracture (Fx), sponsored by Randers Regional Hospital. Primary endpoint: Bone mineral density z-score change. Started Oct 2014; status: completed.
02
Drugs
zoledronic acid
03
Conditions
cerebral palsy (CP)osteopeniabone fracture (Fx)
Beyond the preview
Go deeper on 2014-002118-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002118-21.